Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $150.00, with a market capitalization of 22.98B. The stock trades at a price-to-earnings (P/E) ratio of 34.49.
During the trading session on 2026-01-23, Illumina(ILMN) shares reached a daily high of $155.31 and a low of $148.17. At a current price of $150.00, the stock is +1.2% higher than the low and still -3.4% under the high.
Trading volume for Illumina(ILMN) stock has reached 2.74M, versus its average volume of 1.92M.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
ILMN News
Earlier in January 2026, Illumina announced that the Centers for Medicare and Medicaid Services granted reimbursement for its FDA-approved TruSight Oncology Com...
Illumina (ILMN) announced that reimbursement has been granted for its FDA-approved in vitro diagnostic TruSight Oncology, or TSO, Comprehensive test. TSO Compre...
Stifel analyst Daniel Arias raised the firm’s price target on Illumina (ILMN) to $155 from $135 and keeps a Buy rating on the shares. The firm thinks there is “...